Davis Capital Management’s Alkermes ALKS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$8.47K Sell
209
-3
-1% -$146 0.01% 269
2026
Q2
$11.1K Buy
212
+9
+4% +$351 0.01% 257
2026
Q1
$7.18K Hold
203
– – ﹤0.01% 234
2025
Q4
$5.68K Hold
203
– – ﹤0.01% 250
2025
Q3
$6.09K Buy
+203
New +$5.72K ﹤0.01% 250
2025
Q1
$6.7K Hold
203
– – 0.01% 240
2024
Q4
$5.84K Hold
203
– – ﹤0.01% 253
2024
Q3
$5.68K Hold
203
– – ﹤0.01% 263
2024
Q2
$4.95K Hold
203
– – ﹤0.01% 265
2024
Q1
$5.53K Hold
203
– – ﹤0.01% 240
2023
Q4
$5.63K Buy
+203
New +$5.27K 0.01% 238

Other funds holding ALKS

Davis Capital Management's ALKS Position: Q3 2026 in Review

Davis Capital Management reduced its Alkermes (ALKS) stake by 1.4% in Q3 2026, selling an estimated $146 and leaving 209 shares worth $8.47K. The position accounts for 0.01% of the portfolio, ranked #269.

Davis Capital Management first reported a position in ALKS in Q4 2023 and has held it in 11 quarters since. The position peaked at $11.1K in Q2 2026. 96 funds tracked by Wall St. Rank hold ALKS as of Q3 2026.

  • Davis Capital Management held 209 shares of Alkermes worth $8.47K as of Q3 2026.
  • Davis Capital Management sold 3 Alkermes shares in Q3 2026, an estimated $146.
  • Alkermes made up 0.01% of Davis Capital Management's portfolio in Q3 2026, its #269 holding.
  • Davis Capital Management first reported a position in Alkermes in Q4 2023 and has held it in 11 quarters since.
  • Davis Capital Management's Alkermes position peaked at $11.1K in Q2 2026.
  • 96 funds tracked by Wall St. Rank held Alkermes as of Q3 2026.

Based on Davis Capital Management's 13F filing for Q3 2026, filed 8 Oct 2026.